EVGNMICRO

Evogene Ltd.

HealthcareBiotechnology
$0.42
$0.00(-3.08%)
52W$0.37
$1.50
Updated Jul 8, 02:00 AM
RSI28
RS Rating5/99
Beta1.14
Volatility64%
F-Score4/9
Mkt Cap$4M
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

Evogene Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 5), showing significant lag compared to the market leaders. Earnings contraction of 58% provides fundamental context to the price action. Investors should exercise caution due to high volatility (64% annualized), which requires wider risk management.

Relative Strength
5
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
1.14
vs S&P 500
ABOVE MKT
52W Position
5%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$0.64
50 SMA > 100 SMA$0.73
100 SMA > 150 SMA$0.84
150 SMA > 200 SMA$0.94

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.50-14.95%BELOW
50 SMA$0.64-33.13%BELOW
100 SMA$0.73-42.19%BELOW
150 SMA$0.84-49.62%BELOW
200 SMA$0.94-54.66%BELOW

Price Performance

1D-3.1%
1W-3.2%
1M-27.1%
3M-48.1%
6M-62.7%
YTD-62.4%
1Y-67.8%
3Y-66.0%
52-Week Trading Range5% from low
$0.42
52W Low$0.37
52W High$1.50

Technical Indicators

RSI (14)OVERSOLD
28.4
305070
Setup ScoreCOOL
3/10
Base depth: 115.1%

Risk Profile

Beta
1.14
52W Vol
64%
ATR
$0.04
Max DD (1Y)
-74%

Volume Analysis

Today
59.0K
50D Avg
1.38M
Vol Ratio
0.04x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+42%
$-0.62
Q3'25+134%
$0.44
Q4'25-1071%
$-0.61
Q1'26-58%
$-0.60
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:-10.06%
5 Years:+29.94%
3 Years:+32.01%
TTM:-16.20%

Compounded Profit Growth

10 Years:-4.73%
5 Years:
3 Years:
TTM:+48.27%

Stock Price CAGR

10 Years:-39.25%
5 Years:-57.57%
3 Years:-65.99%
1 Year:-67.82%

Return on Equity

10Y Avg:-46.9%
5Y Avg:-62.9%
3Y Avg:-71.4%
Last Year:-110.7%

Key Metrics

Market Cap$4M
Gross Margin-6.3%
Net Margin-2.2%
Piotroski F-Score4/9

Frequently Asked Questions

Is EVGN in an uptrend right now?

EVGN has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is EVGN overbought or oversold?

EVGN's RSI (14) is 28. The stock is oversold (RSI < 30), which could indicate a bounce opportunity.

Is EVGN outperforming the market?

EVGN has a Relative Strength (RS) Rating of 5 out of 99. EVGN is currently lagging the broader market.

Where is EVGN in its 52-week range?

EVGN is trading at $0.42, which is 28% of its 52-week high ($1.50) and 5% above its 52-week low ($0.37).

How volatile is EVGN?

EVGN has a Beta of 1.14 and 52-week volatility of 64%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.